Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.As of 15 Jun 2026, Jagsonpal Pharmaceuticals share price is ₹211.39. The stock opened at ₹213.80, compared to its previous close of ₹209.63. During today's trading session, Jagsonpal Pharmaceuticals share price moved in the range of ₹210.50 to ₹219.36, with an average price of ₹214.93 for the day. Looking at its last 52-week, the stock has touched a low of ₹210.50 and a high of ₹219.36. On the performance front, Jagsonpal Pharmaceuticals share price has increased by 4.42% over the last six months and is down 10.05% on a year-on-year basis.
The market capitalization of Jagsonpal Pharmaceuticals is ₹1,388 Crs, with a P/E ratio of 32.2 and a dividend yield of 1.93%.